{"id":60790,"date":"2026-02-04T12:30:03","date_gmt":"2026-02-04T07:00:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=60790"},"modified":"2026-02-04T12:30:05","modified_gmt":"2026-02-04T07:00:05","slug":"accretion-nutraveda-ipo-listing","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/","title":{"rendered":"Accretion Nutraveda IPO Listing at 48% Premium at \u20b9191 Per Share\u00a0"},"content":{"rendered":"<p><strong>Accretion Nutraveda IPO Listing Today: <\/strong>The Accretion Nutraveda IPO was subscribed 1.83 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 1.01 times, and non-institutional investors (NIIs) received 2.08 times. The retail quota of the issue was subscribed to 33.33%. Before delving deeper into the topic, go through the details of the Accretion Nutraveda IPO.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Accretion_Nutraveda_IPO\" title=\"Accretion Nutraveda IPO\">Accretion Nutraveda IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Accretion_Nutraveda_IPO_Listing\" title=\"Accretion Nutraveda IPO Listing\">Accretion Nutraveda IPO Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#About_the_Accretion_Nutraveda_IPO\" title=\"About the Accretion Nutraveda IPO\">About the Accretion Nutraveda IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Business_segments\" title=\"Business segments:\">Business segments:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Accretion_Nutraveda_Limited_Financials\" title=\"Accretion Nutraveda Limited Financials\">Accretion Nutraveda Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-listing\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO\"><\/span><strong>Accretion Nutraveda IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>It is a bookbuilding IPO of \u20b924.77 crore, comprising an entirely fresh issue of 0.19 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 2nd February 2026. The Accretion Nutraveda IPO date is scheduled for 28th January 2026 to 30th January 2026. The face value of Accretion Nutraveda shares stands at \u20b910 per share, and the IPO Issue price band is set at \u20b9122 to \u20b9129 per share<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>2nd February 2026<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>28th January 2026<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>30th January 2026<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>3rd February 2026<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>19,20,000 shares(agg. up to \u20b925 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>2,000 Shares<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td>\u20b9122 to \u20b9129 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>4th February 2026<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Listing\"><\/span><strong>Accretion Nutraveda IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the BSE &amp; SME platforms, Accretion Nutraveda shares are listed at \u20b9191 per share, reflecting a 48% premium over the issue price of \u20b9129 per share.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_the_Accretion_Nutraveda_IPO\"><\/span><strong>About the Accretion Nutraveda IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Nutraveda Limited was incorporated in 2021. Accretion Nutraveda is involved in the manufacturing of Ayurvedic &amp; Nutraceutical products in various forms, such as tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels. The company is a Contract Development and Manufacturing Organization (CDMO) catering to the domestic as well as international markets such as Sri Lanka, Singapore, and the USA. The products are a blend of traditional Ayurvedic practices and advanced nutraceutical science targeting areas such as liver support, women\u2019s health, bone &amp; joint support, cognitive function, and respiratory wellness.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Business_segments\"><\/span><strong>Business segments:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Domestic Sales &amp; Merchant Exports (Loan License Basis)\u2013 accounting for 96.62% of total revenue in FY 2024-25.<\/li>\n\n<li>Direct Exports\u2013 Accounting for 38%, registering steady growth.<\/li><\/ul><p>It has a manufacturing unit in Gujarat occupying approximately 10,763 sq. ft. with modern infrastructure such as 13 air handling units, processing areas, and quality control mechanisms. The unit is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified with FSSAI license.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_Limited_Financials\"><\/span><strong>Accretion Nutraveda Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Accretion Nutraveda IPO. <\/strong>See the table for Accretion Nutraveda Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th Sep 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>16.35<\/td><td>10.86<\/td><td>4.64<\/td><td>4.06<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>14.07<\/td><td>16.06<\/td><td>5.20<\/td><td>3.07<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>2.33<\/td><td>2.61<\/td><td>0.82<\/td><td>0.28<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>3.29<\/td><td>3.65<\/td><td>1.21<\/td><td>0.59<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>8.26<\/td><td>5.35<\/td><td>1.08<\/td><td>0.26<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>2.95<\/td><td>4.86<\/td><td>0.72<\/td><td>-0.10<\/td><\/tr><tr><td><strong>Total Borrowings<\/strong><\/td><td>4.43<\/td><td>3.86<\/td><td>2.17<\/td><td>1.97<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Accretion Nutraveda Limited&#8217;s revenue increased by 208.84% from \u20b95.20 crores in March 2024 to \u20b916.06 crores in March 2025. Moreover, the company&#8217;s PAT increased by 218.29% from \u20b90.82 crores in March 2024 to \u20b92.61 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/ckk-retail-mart-ipo-gmp-subscription-day-3\">CKK Retail Mart IPO Day 3: 0.92x Subscribed as GMP Stays Flat \u2014 Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/ckk-retail-mart-ipo-allotment-status\">CKK Retail Mart IPO Allotment Status: 0.92x Subscribed, GMP Flat \u2014 Check Online<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/biopol-chemicals-ipo-review\">Biopol Chemicals IPO Review 2026: GMP Steady, Key Investor Insights<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/pan-hr-solutions-ipo-review\">PAN HR Solutions IPO Review 2026: GMP Steady, Key Investor Insights<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/kasturi-metal-ipo-listing-today\">Kasturi Metal IPO Listing Today: IPO Flat at \u20b964, Subscribed 17.75x<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Accretion Nutraveda IPO Listing Today: The Accretion Nutraveda IPO was subscribed 1.83 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 1.01 times, and non-institutional investors (NIIs) received 2.08 times. The retail quota of the issue was subscribed to 33.33%. Before delving deeper into the topic, go through the<\/p>\n","protected":false},"author":23,"featured_media":60791,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,3808],"class_list":["post-60790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-ipo-listing"],"metadata":{"_edit_lock":["1770188412:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["71"],"rank_math_title":["Accretion Nutraveda IPO Listing Today; Check Share Price in 2026"],"rank_math_description":["Accretion Nutraveda IPO Listing at \u20b9191 at a premium of 48% against the IPO price of \u20b9129 per share. What should be your next move on the Accretion Nutraveda IPO? Read more to know.\n"],"rank_math_focus_keyword":["Accretion Nutraveda IPO Listing"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["60791"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["6190"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/04122659\/Accretion-Nutraveda-IPO-Listing-Today.jpg.jpeg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/60790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=60790"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/60790\/revisions"}],"predecessor-version":[{"id":60792,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/60790\/revisions\/60792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/60791"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=60790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=60790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=60790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}